These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7629800)

  • 1. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
    Xu J; Kullgren B; Durbin PW; Raymond KN
    J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
    Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
    J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
    Uhlir LC; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo: comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Int J Radiat Biol; 2000 Feb; 76(2):199-214. PubMed ID: 10716641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive binding of Pu and Am with bone mineral and novel chelating agents.
    Guilmette RA; Hakimi R; Durbin PW; Xu J; Raymond KN
    Radiat Prot Dosimetry; 2003; 105(1-4):527-34. PubMed ID: 14527022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands.
    White DL; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1988 Jan; 31(1):11-8. PubMed ID: 2826783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Health Phys; 1997 Jun; 72(6):865-79. PubMed ID: 9169929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacy.
    Durbin PW; Kullgren B; Xu J; Raymond KN; Hengé-Napoli MH; Bailly T; Burgada R
    Radiat Prot Dosimetry; 2003; 105(1-4):503-8. PubMed ID: 14527018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones.
    Durbin PW; Kullgren B; Jeung N; Xu J; Rodgers SJ; Raymond KN
    Hum Exp Toxicol; 1996 Apr; 15(4):352-60. PubMed ID: 8845226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).
    Abergel RJ; Durbin PW; Kullgren B; Ebbe SN; Xu J; Chang PY; Bunin DI; Blakely EA; Bjornstad KA; Rosen CJ; Shuh DK; Raymond KN
    Health Phys; 2010 Sep; 99(3):401-7. PubMed ID: 20699704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice.
    Durbin PW; Kullgren B; Ebbe SN; Xu J; Raymond KN
    Health Phys; 2000 May; 78(5):511-21. PubMed ID: 10772024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelation therapy by DFO-HOPO and 3,4,3-LIHOPO for injected Pu-238 and Am-241 in the rat: effect of dosage, time and mode of chelate administration.
    Volf V; Burgada R; Raymond KN; Durbin PW
    Int J Radiat Biol; 1996 Dec; 70(6):765-72. PubMed ID: 8980674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 237Np: oxidation state in vivo and chelation by multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW; Kullgren B; Xu J; Raymond KN; Allen PG; Bucher JJ; Edelstein NM; Shuh DK
    Health Phys; 1998 Jul; 75(1):34-50. PubMed ID: 9645664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals.
    Sturzbecher-Hoehne M; Choi TA; Abergel RJ
    Inorg Chem; 2015 Apr; 54(7):3462-8. PubMed ID: 25799124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates.
    Turcot I; Stintzi A; Xu J; Raymond KN
    J Biol Inorg Chem; 2000 Oct; 5(5):634-41. PubMed ID: 11085654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plutonium(IV) sequestration: structural and thermodynamic evaluation of the extraordinarily stable cerium(IV) hydroxypyridinonate complexes.
    Xu J; Radkov E; Ziegler M; Raymond KN
    Inorg Chem; 2000 Sep; 39(18):4156-64. PubMed ID: 11198875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
    Durbin PW
    Health Phys; 2008 Nov; 95(5):465-92. PubMed ID: 18849679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ beam reduction of Pu(IV) and Bk(IV) as a route to trivalent transuranic coordination complexes with hydroxypyridinone chelators.
    Carter KP; Wacker JN; Smith KF; Deblonde GJP; Moreau LM; Rees JA; Booth CH; Abergel RJ
    J Synchrotron Radiat; 2022 Mar; 29(Pt 2):315-322. PubMed ID: 35254293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen.
    Bunin DI; Chang PY; Doppalapudi RS; Riccio ES; An D; Jarvis EE; Kullgren B; Abergel RJ
    Radiat Res; 2013 Feb; 179(2):171-82. PubMed ID: 23289385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.
    Deblonde GJ; Sturzbecher-Hoehne M; Abergel RJ
    Inorg Chem; 2013 Aug; 52(15):8805-11. PubMed ID: 23855806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.